New arthritis drug for kids shows promise in early trial

NCT ID NCT07517575

Recruiting now Disease control Sponsor: R-Pharm International, LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a drug called olokizumab in children aged 2 to 18 with active juvenile idiopathic arthritis. The drug is given as a shot under the skin every 4 weeks. Researchers want to see how the drug moves through the body, if it helps control arthritis symptoms, and if it is safe. About 71 children will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: olokizumab (Artlegia), a drug given as a shot under the skin every 4 weeks
What this could lead to: If successful, this could provide a new treatment option for children with juvenile idiopathic arthritis to better control their disease.
What could go wrong: This is an early phase 2 study with only 71 participants, so results may not apply to all children. The drug may not work as well as hoped or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritic joint disease autoimmune disease juvenile idiopathic arthritis musculoskeletal system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

JUVENILE IDIOPATHIC ARTHRITIS

Contacts and locations

Locations

Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)
RECRUITING

Moscow, 119435, Russia
Federal State Autonomous Institution "National Medical Research Center for Children's Health" of the Ministry of Health of the Russian Federation
RECRUITING

Moscow, 119991, Russia
Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Health of the Russian Federation
RECRUITING

Ufa, 450083, Russia
Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation
RECRUITING

Kazan', 420012, Russia
Federal State Budgetary Educational Institution of Higher Education "Rostov State Medical University" of the Ministry of Health of the Russian Federation
RECRUITING

Rostov-on-Don, 344022, Russia
Federal State Budgetary Educational Institution of Higher Education "Saratov State Medical University named after V.I. Razumovsky" of the Ministry of Health of the Russian Federation
RECRUITING

Saratov, 410054, Russia
Federal State Budgetary Educational Institution of Higher Education "Voronezh State Medical University named after N.N. Burdenko" of the Ministry of Health of the Russian Federation
RECRUITING

Voronezh, 394036, Russia
Federal State Budgetary Scientific Institution "V.A. Nasonova Research Institute of Rheumatology"
RECRUITING

Moscow, 115522, Russia
LLC "Medical Technologies"
RECRUITING

Saint Petersburg, 192148, Russia
Limited Liability Company "Healthy Family Medical Center"
RECRUITING

Novosibirsk, 630099, Russia
Limited Liability Company "Scientific Medical Center of General Therapy and Pharmacology" (LLC "TERAPHARM")
RECRUITING

Stavropol, 55000, Russia
State Budgetary Healthcare Institution of the Samara Region "Tolyatti City Clinical Hospital No. 5"
RECRUITING

Tolyatti, 445039, Russia
State Budgetary Institution of Healthcare of the City of Moscow "Morozovskaya Children's City Clinical Hospital of the Moscow City Health Department" (GBUZ "Morozovskaya DGBK DZM")
RECRUITING

Moscow, 119049, Russia
State Budgetary Institution of Healthcare of the Yaroslavl Region "Regional Children's Clinical Hospital"
RECRUITING

Yaroslavl, 150000, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.